一管血就能验癌的公司,成功上市了。5月23日,Mirxes觅瑞正式登陆港交所。截至发稿,这家miRNA明星公司市值超过85亿港元。在朱兴奋教授与博士周砺寒、邹瑞阳这对师徒的带领下,Mirxes觅瑞目前拥有三种已商业化产品和六种处于临床前阶段的候选产品,一年的收入达到约1.46亿元。其中,用于胃癌早筛的核心产品,通过一管(1毫升)血液即可实现检测。一路走来,Mirxes觅瑞获得淘宝前总裁孙彤宇、高榕...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.